Comments
Loading...
As of Feb 28, 2025
Number of Stock Holdings
82
Number of Bond Holdings
-
Total Holdings
85
Number of ETFs
-
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM), Top Holdings
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)
| Ticker | Name | Share % | |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc. | 3.90% | |
| RNA | Avidity Biosciences Inc | 5.52% | |
| TECH | Bio-Techne Corp | 4.15% | |
| LEGN | Legend Biotech Corp | 4.29% | |
| ARWR | Arrowhead Pharmaceuticals Inc | 4.43% | |
| NTLA | Intellia Therapeutics Inc | 4.19% | |
| MYGN | Myriad Genetics Inc | 4.08% | |
| SRPT | Sarepta Therapeutics Inc | 3.94% | |
| NTRA | Natera Inc | 6.12% | |
| MRNA | Moderna Inc | 3.76% | |
| VCYT | Veracyte, Inc. | 5.00% | |
| A | Agilent Technologies Inc | 4.49% | |
| FF | Biontech Se Adr | 4.74% | |
| SG | Qiagen N.V. | 4.13% | |
| ILMN | Illumina, Inc. | 3.93% | |
| BMRN | Biomarin Pharmaceutical Inc. | 4.74% | |
| SM | Crispr Therapeutics Ag | 4.45% | |
| BEAM | Beam Therapeutics Inc | 4.17% | |
FAQ
How has GNOM ETF performed?
The GNOM ETF is currently trading at $8.57, which represents a -1.45% change. Over the past 52 weeks, the ETF has traded as high as $11.88 and as low as $8.54.
What is the expense ratio for GNOM?
The expense ratio of GNOM is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.
What is the Assets Under Management (AUM) for GNOM?
The total Assets Under Management (AUM) for GNOM is 56.51M. This represents the total market value of the assets managed by the ETF.
What is the investment style for GNOM?
GNOM follows a Mid Cap Growth investment style.
What are the top holdings for GNOM?
The top holdings of GNOM include: ALNY (3.9%), RNA (5.52%), TECH (4.15%), LEGN (4.29%), ARWR (4.43%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for GNOM?
Average daily volume data for GNOM is currently not available.